氨酶系统调节了SARS-CoV-2通过ACE2受体进入
bioRxiv : the preprint server for biology
|July 16, 2025
概括
ангиотензин IV 独特地影响SARS-CoV-2 进入,在低度下增强它,在高度下抑制它. 这种是这种.
科学领域:
- 心血管监管 监管心血管系统
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 氨酶系统 (RAS) 对于心血管调节至关重要.
- ACE2是SARS-CoV-2进入宿主细胞的关键受体.
- ангиотензин IV,但不是 ангиотензин II,可能会影响SARS-CoV-2与ACE2的结合.
研究的目的:
- 为了研究抗胰岛素IV对SARS-CoV-2结合ACE2的影响的病毒学意义.
- 为了确定 ангиотензинII和 ангиотензинIV对SARS-CoV-2病毒输入的影响.
- 探索针对COVID-19中RAS的潜在治疗策略.
主要方法:
- 开发使用SARS-CoV-2病毒样颗粒的一次性感染试验.
- 在一系列的 ангиотензинII和 ангиотензинIV度中测试病毒感染性.
- 在基分子对接模拟中预测-蛋白相互作用.
主要成果:
- ангиотензин II 没有影响病毒感染性.
- ангиотензин IV 证明了双重作用:在低度下增强病毒的进入,在更高度下抑制病毒的进入.
- 分子对接表明angiotensin IV与SARS-CoV-2尖端蛋白的S1域相关.
结论:
- ангиотензин IV 在调节SARS-CoV-2 进入过程中发挥着独特的,依赖于度的作用.
- 抗胰岛素IV的生理度可能会促进SARS-CoV-2感染.
- 这项研究揭示了RAS和COVID-19病理生理学之间的新联系,表明了新的治疗途径.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
892
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
892
Antihypertensive Drugs: Direct Renin Inhibitors
833
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
833
Antihypertensive Drugs: Angiotensin II Receptor Blockers
930
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
930
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
513
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
513
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Hypertension II: Pathophysiology
88
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
88


